Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status

By Lee Hoon   Buchholz Thomas  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 55-56

Informa Healthcare

Access to resources Recommend Favorite

Clinical presentation and surgical quality in treatment of ductal carcinoma in situ of the breast

By Schouten Van Der Velden Arjan   Peeters Petra   Koot Veronica   Hennipman Adriaan  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 544-549

Informa Healthcare

Access to resources Recommend Favorite

Multifocal intracranial germinoma with raised tumour markers in serum but not in CSF and with carcinoma in situ of the testis

By Jorsal Tina   Rørth Mikael  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 127-129

Informa Healthcare

Access to resources Recommend Favorite

Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab

By Dybdal Noël   Leiberman Grazyna   Anderson Steven   McCune Bryan   Bajamonde Alex   Cohen Robert   Mass Robert   Sanders Corsee   Press Michael  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 3-11

Springer Publishing Company

Access to resources Recommend Favorite

Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast‐conserving therapy

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 56-63

John Wiley & Sons Inc

Access to resources Recommend Favorite